Transcendental meditation and components of the metabolic syndrome: Methodological issues [1]

Archives of Internal Medicine

Volumn 166, Issue 22, 2006, Pages 2553-

  Andrade, Chittaranjan ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ALTERNATIVE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EXERCISE; HUMAN; ISCHEMIC HEART DISEASE; LETTER; METABOLIC SYNDROME X; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLING; TRANSCENDENTAL MEDITATION; TREATMENT RESPONSE; YOGA;

EID: 33845478933     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.22.2553-a     Document Type: Letter

References (4)

1. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006;166:1218-1224.
2. Miller GA, Chapman JP. Misunderstanding analysis of covariance. J Abnorm Psychol. 2001;110:40-48.
3. Andrade C. Yoga: Some unanswered questions [letter]. Indian J Psychiatry. 1995;37:189.
4. Andrade C. Yoga: better treatment or better placebo [letter]? Indian J Psychiatry. 2002;44:83.